• News: Invicro Launches AmyloidIQ to Advance Clinical Imaging Trials in Alzheimer’s Disease

    Boston, MA (March 19,  2018) – Invicro LLC, a Konica Minolta company and a leading provider of imaging services and software for research and drug development, recently announced the launch of AmyloidIQ, a new and advanced algorithm that quantifies Amyloid scans for use in subject stratification and clinical trials of Alzheimer’s disease therapies. SEE MORE

    • News: Invicro Hires Edward Hogan as Senior Vice President of Clinical Operations

    • Boston, MA (February 27,  2018) – Invicro, LLC, a Konica Minolta company and a leading provider of imaging services and software for research and drug development, today announced the hiring of Mr. Edward Hogan, M.S. as Senior Vice President of Clinical Operations. SEE MORE

      • News: Invicro Appoints George Abe as Senior Vice President, Pathology

      • Boston, MA (February 20,  2018) – Invicro LLC, a Konica Minolta company and a leading provider of imaging services and software for research and drug development, today announced the hiring of Mr. George Abe, as Senior Vice President of Pathology. SEE MORE

        • News: Ambry Genetics and Invicro Announce Partnership to Provide Enhanced Capabilities with Advanced Genomics Services to Enable Precision Medicine

        • Aliso Viejo, CA (January 31,  2018) – Partnership provides Pharmaceutical Companies a more Comprehensive Solution in an Effort to Improve Patient Care. SEE MORE

          • News: Boston-Based Invicro Further Expands Imaging Capabilities with Acquisition of Core Clinical, Inc.

          • BOSTON, MA (October 26, 2017) – Invicro, LLC, a leading provider of imaging services and software for research and drug development, announced today that it has completed the acquisition of Core Clinical, Inc., a medical imaging core lab based in Bucks County, PA. SEE MORE

        • News: Konica Minolta Accelerates Expansion of Precision Medicine Business Through Acquisition of US-based Pharmaceutical Research Company, Invicro

          BOSTON, MA (September 25, 2017) –  Through molecular digital imaging technology, acquisition offers new value for drug discovery and development focused on the fields of immuno-oncology and neurodegenerative disease SEE MORE

        • News: Invicro Acquires Imanova

          BOSTON, MA (September 12, 2017) –  Invicro, a leading provider of imaging services and software for research and drug development, announced today the acquisition of Imanova UK-based Imanova. Invicro and Imanova will merge all activities to establish the world’s largest provider of translational imaging services and analytics from pre-clinical development through to late-phase clinical trials. SEE MORE

        • Events: 2017 Invicro Software User Meeting

          BOSTON, MA (August 19, 2017) –  Click here to register for this event.

        • Events: Invicro at WMIC 2017

          BOSTON, MA (August 19, 2017) –  Visit our team at booth 403.  SEE MORE

        • News: Bioverativ and Invicro Form Novel, Advanced Imaging Collaboration

          WALTHAM, Mass. & BOSTON, Mass – August 24, 2017 – Bioverativ Inc. (NASDAQ: BIVV), a global biotechnology company focused on the discovery, development and commercialization of innovative therapies for hemophilia and other rare blood disorders, and Invicro, LLC, a leading provider of imaging services and analysis for pharmaceutical research and development, today announced that they have formed a strategic collaboration focused on expanding the use and adoption of leading imaging technologies, including ultrasound and radiolabeled imaging, to improve the diagnosis and management of joint disease in people with hemophilia. SEE MORE

        • Events: Invicro at SNMMI 2017

          BOSTON, MA (June 3, 2017) –  Visit our team at booth 775.  SEE MORE

        • Events: Invicro at Bio-IT World 2017

          BOSTON, MA (May 8, 2017) –  Visit our team at booth #528, and join us for beer and wine at our booth from 5:30 – 6:30PM on Wednesday, May 24!

        • Events: Invicro at WMIC 2016

          BOSTON, MA (August 26, 2016) – Read more about our attendance at WMIC, including presentations by our team.  SEE MORE

        • Webinar: High-Throughput Three-Dimensional Tissue Imaging in the Bright-Field, Fluorescence and Nuclear Regimes | June 8 | 11am EST

          In this talk, Jack Hoppin, Invicro co-founder, focuses on the strengths and limitations of these emerging translational tomographic techniques and technologies and evaluates their application as imaging biomarker tools.

          Get access to the recorded webinar here.

        • Events: Invicro at SNMMI 2016

          BOSTON, MA (June 10, 2016) – Read more about our attendance at SNMMI, including presentations by our team.  SEE MORE

        • News: Invicro Featured in WMIS Video Contest

          BOSTON, MA (June 8, 2016) – Invicro is the proud winner of the 2015 WMIS “This is Our Lab” Contest.  Winners were featured in a video to showcase their work, and the final product has been released on the WMIS website.  SEE MORE

        • Event: Invicro Hosts Translational Imaging Symposium in Boston

          BOSTON, MA (May 12, 2016) Leaders in translational molecular imaging will be presenting on the latest innovations and emerging global trends in the field. We look forward to hosting another event which will provide a forum for thought-leaders in translational imaging to share insights into the latest advancements in the field. SEE MORE

        • News: AXT Brings Invicro’s Preclinical Medical Imaging Products to Australia

          BOSTON, MA (April 5, 2016) AXT has recently bolstered their preclinical and translational imaging products portfolio with the addition of Invicro’s innovative software platforms. SEE MORE

        • News: inviCRO Acquires Molecular NeuroImaging (MNI) to Establish Full Spectrum Translational Imaging Capabilities

          BOSTON, MA (February 25, 2016) – Invicro, LLC, and Molecular NeuroImaging, LLC, both leading providers of imaging service solutions and analysis software for research and drug development, announced they will merge all activities to provide the most comprehensive set of imaging services across the spectrum of drug development. Invicro has acquired MNI and MNI will operate as a division of inviCRO. SEE MORE

        • Events: Invicro Hosts Software User Meeting

          BOSTON, MA (September 29, 2015) – Invicro’s first Software User Meeting was held on September 23rd at Boston’s District Hall, and was attended by more than 70 inviCRO software users (in person and remote). SEE MORE

        • Publications: Invicro Scientific Presentations at WMIC 2015

          Abstracts:

          Cryoflourescence Tomography (CFT) is an Ex Vivo Tool to Study Anatomy, Physiology, and Drug or Tracer Distribution in Brain and Other Organs SEE MORE

        • Events: Invicro at the 2015 World Molecular Imaging Congress

          BOSTON, MA (September 29, 2015) – Five Invicro teammates were pleased to attend September’s World Molecular Imaging Congress and continued to focus on fostering industry and academia relations… SEE MORE

        • News: Invicro Expands Preclinical Histology Service Capabilities with the Opening of inviCRO Seattle

          inviCRO expands 2D/3D histology imaging and analysis services for research and drug development  

          BOSTON, MA (March 20, 2015) – Invicro announced today its expansion of histology capabilities with the acquisition of a Seattle-based histology team and the opening of inviCRO Seattle. SEE MORE

          • Software Release: Introducing VivoQuant 2.0

            BOSTON, MA (February 25, 2015) – Invicro is excited to announce the release of VivoQuant 2.0! Based on the valuable feedback of our customers, we have improved VivoQuant’s user experience, making it more intuitive and even easier to interact with.  SEE MORE

          • Software Release: Invicro Partners with FUJIFILM VisualSonics, Inc. to Develop the VisualSonics iPACS® Imaging Study Management System

            TORONTO, CANADA ( December 4, 2014) – FUJIFILM VisualSonics Inc., a world leader in real-time, in vivo, high-resolution micro-imaging systems designed specifically for pre-clinical research and a subsidiary of FUJIFILM SonoSite, Inc, is pleased to announce a new and exclusive partnership with Invicro, LLC, and the development of the VisualSonics iPACS® Imaging Study Management System. SEE MORE

          Archived News

              Contact the Author:

              Kat Ramey | T. +1.617-904-2117 | E. kramey@invicro.com